[ Price : $8.95]
FDA warns Chinas Xiamen Kang Zhongyuan Biotechnology Co. about producing drugs in insanitary conditions and making misleading or d...[ Price : $8.95]
Two pharmacy professors say FDA needs to solicit expert and client input on its new Adverse Event Monitoring System dashboard and ...[ Price : $8.95]
FDA accepts a Roche supplemental BLA that seeks to expand use of Gazyva to treat Systemic Lupus Erythematosus.[ Price : $8.95]
FDA commissioner Marty Makary tells Fox Business that the agency will deploy its new national priority voucher program to signific...[ Price : $8.95]
FDA approves Mercks Idvynso, a once-daily, single-tablet regimen for adults with HIV-1 who are already virologically suppressed.[ Price : $8.95]
Outlook Therapeutics completes a formal dispute resolution meeting with FDA as part of the companys push to revive its approval pr...[ Price : $8.95]
FDA warns the University of California at San Francisco radiopharmaceutical facility about CGMP violations in its production of fi...[ Price : $8.95]
FDA warns Par USA/Endo USA about CGMP violations in its manufacturing of finished drugs.